GAMMA Investing LLC Increases Holdings in Exponent, Inc. (NASDAQ:EXPO)

GAMMA Investing LLC increased its stake in Exponent, Inc. (NASDAQ:EXPO) by 64.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 624 shares of the business services provider’s stock after acquiring an additional 245 shares during the period. GAMMA Investing LLC’s holdings in Exponent were worth $72,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in EXPO. Vanguard Group Inc. boosted its holdings in shares of Exponent by 5.8% in the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after purchasing an additional 291,047 shares during the period. Kayne Anderson Rudnick Investment Management LLC boosted its stake in Exponent by 6.5% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after buying an additional 284,179 shares during the period. Conestoga Capital Advisors LLC increased its position in Exponent by 2.8% during the second quarter. Conestoga Capital Advisors LLC now owns 2,763,260 shares of the business services provider’s stock valued at $262,841,000 after acquiring an additional 75,909 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Exponent by 0.6% in the second quarter. Dimensional Fund Advisors LP now owns 1,019,085 shares of the business services provider’s stock valued at $96,937,000 after acquiring an additional 6,108 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Exponent by 3.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 534,520 shares of the business services provider’s stock worth $50,844,000 after acquiring an additional 17,849 shares during the last quarter. 92.37% of the stock is owned by institutional investors.

Exponent Stock Up 0.6 %

EXPO opened at $113.79 on Wednesday. The business has a fifty day moving average of $108.20 and a 200 day moving average of $98.70. The stock has a market cap of $5.77 billion, a P/E ratio of 57.47 and a beta of 0.66. Exponent, Inc. has a 52-week low of $64.61 and a 52-week high of $115.61.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, July 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. The firm had revenue of $132.43 million during the quarter, compared to analyst estimates of $130.83 million. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The business’s revenue was up 2.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.50 earnings per share. Equities analysts anticipate that Exponent, Inc. will post 2.04 EPS for the current fiscal year.

Exponent Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date was Friday, September 6th. Exponent’s dividend payout ratio (DPR) is presently 56.57%.

Insider Activity

In related news, VP John Pye sold 3,956 shares of the stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now owns 28,422 shares of the company’s stock, valued at $2,984,310. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.10% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Truist Financial reiterated a “buy” rating and set a $120.00 price target (up from $100.00) on shares of Exponent in a report on Friday, July 26th.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.